The combination of Valproic acid with Coumarin-3-carboxylic acid (3-Carboxycoumarin) suppresses the proliferation and migration of lung cancer cells via EGFR/VEGFR2/c-Met-Akt-NF-kappaB signaling pathways, this combination may have a wide therapeutic and/or adjuvant therapeutic application in the treatment of lung cancer.
Molecular Weight:
190.15
Purity:
99.76%
CAS Number:
[531-81-7]
Formula:
C10H6O4
Target:
Others|||VEGFR
TJS0339
* VAT and and shipping costs not included. Errors and price changes excepted